Back
TherapeuticsMD, Inc. 10K Form
Sell
38
TXMD
TherapeuticsMD, Inc.
Last Price:
$1.95
Seasonality Move:
-4.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TXMD News And Ratings
See the #1 stock for the next 7 days that we like better than TXMD
TXMD Financial Statistics
Sales & Book Value
| Annual Sales: | $3M |
|---|---|
| Cash Flow: | $1M |
| Price / Cash Flow: | 9.55 |
| Annual Sales: | $2.37 |
| Price / Book: | 0.86 |
Profitability
| EPS (TTM): | 0.02600 |
|---|---|
| Net Income (TTM): | $73K |
| Gross Margin: | $1.8M |
| Return on Equity: | 0.27% |
| Return on Assets: | 0.19% |
TherapeuticsMD, Inc. Earnings Forecast
Key TherapeuticsMD, Inc. Financial Ratios
-
The Gross Profit Margin over the past 33 years for TXMD is 60.52%.
-
The Selling, General & Administrative Expenses for TXMD have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of TXMD is -21.61% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 18 years.
TherapeuticsMD, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TXMD |
| CUSIP: | 88338N |
| Website: | therapeuticsmd.com |
Debt
| Debt-to-Equity Ratio: | 0.24 |
|---|---|
| Current Ratio: | 2.46 |
| Quick Ratio: | 1.44 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TXMD Technical Analysis vs Fundamental Analysis
Sell
38
TherapeuticsMD, Inc. (TXMD)
is a Sell
Is TherapeuticsMD, Inc. a Buy or a Sell?
-
TherapeuticsMD, Inc. stock is rated a SellThe current TherapeuticsMD, Inc. [TXMD] share price is $2.00. The Score for TXMD is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.